2022 What's Next for World Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents—A 90-Country Transfusion Market Analysis—Emerging Opportunities, Supplier Shares, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2026-Competitive Strategies, Latest Technologies, Instrumentation Pipeline

July 2022 | - | ID: 2DF9399E93BBEN
Venture Planning Group

Abstracts

This new 90-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report is available by section, and can be customized to specific information needs and budget.

The report explores future market and technological trends; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Group Genotyping

PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing

Microarrays

BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates for leading suppliers of blood typing, grouping and infectious disease screening tests in major countries.

Geographic Regions

Asia-Pacific, Europe, Latin America, Middle East, North America

Country Analyses

Albania, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, El Salvador, Estonia, Finland, France, Georgia, Germany, Greece, Guatemala, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Moldova, Myanmar, Netherlands, New Zealand, Nicaragua, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovak Republic, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, UK, Ukraine, United Arab Emirates, Uruguay, USA, Venezuela, Vietnam

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, M&A, product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis

• Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers.
• Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT assays.

Current and Emerging Products

• Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays.
• Review of automated and semi-automated molecular and immunohematology analyzers.

Technology Review

• Assessment of current and emerging technologies, and their potential applications for the blood banking market.
• Companies developing or marketing new technologies and products, by test.

Strategic Recommendations

• New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET OVERVIEW

A. Business Environment
B. Market Structure

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection

VI. WORLDWIDE TECHNOLOGY AND MARKET OVERVIEW

A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
  1. Blood Typing and Grouping Tests
    a. ABO
    b. Antibody Panels
    c. Antibody Screening
    d. Antigen Typing
    e. Antiglobulin Test
    f. Crossmatch
    g. HLA Typing
    h. Rh
    i. Other Blood Groups
  2. Infectious Disease Screening Tests
    a. AIDS/HIV
  Background
  Diagnostic Tests
    Enzyme Immunoassay
    Viral Load/Drug Resistance Testing
    Genotype and Phenotype Testing
  Blood Banking Considerations
    b. Hepatitis Markers
  Hepatitis A
  Hepatitis B
  Hepatitis C
  Hepatitis D (Delta Hepatitis)
  Hepatitis E
  Hepatitis G
  Vaccines and Drugs
    c. Cytomegalovirus
  Background
  Diagnostic Tests
  Vaccines and Drugs
    d. Syphilis
  Background
  Diagnostic Tests
  Vaccines and Drugs
    e. West Nile Virus
  Background
  Clinical Syndromes
  Diagnostic Tests
  Vaccines and Drugs
    f. Parvovirus B19
  Microbiology
  Epidemiology
  Clinical Syndromes
  Diagnostic Test
  Vaccines and Drugs
    g. Creutzfeldt-Jakob’s Disease
  Background
  Transmission
  Diagnostic Tests
  Vaccines and Drugs
    h. Malaria
    i. Chagas Disease
    j. Babesiosis
  3. Pathogen Reduction
  4. Leukocyte Reduction
  Background
  Methods
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Blood Typing, Grouping and Infectious Disease Screening Automated and Semiautomated Analyzers
C. Major Blood Banking Technologies and Their Potential Applications
  1. Molecular Diagnostics
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
  4. Microtitration Plates
  5. IT and Automation
  6. Lasers
  7. Robotics
  8. Synthetic Red Cell Substitutes
  9. Genetically Engineered Blood Components
  10. Blood Preservation
  11. Autologous Blood Transfusion/Freezing

VII. COUNTRY MARKET ANALYSES: BLOOD TYPING, GROUPING AND INFECTIOUS DISEASE SCREENING TEST VOLUME AND SALES FORECASTS FOR 90 COUNTRIES:

Albania, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, El Salvador, Estonia, Finland, France, Georgia, Germany, Greece, Guatemala, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Moldova, Myanmar, Netherlands, New Zealand, Nicaragua, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Saudi
Arabia, Serbia, Singapore, Slovak Republic, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, Ukraine, United Arab Emirates, Uruguay, USA, Venezuela, Vietnam

VIII. COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Grifols
Hologic
Immucor
LabCorp
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens Healthineers
Tecan
Thermo Fisher